Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Alefacept in Combination With Narrow-band UVB (nbUVB) Compared to Alefacept Alone in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00658606 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00658606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00658606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Alefacept in Combination With Narrow-band UVB (nbUVB) Compared to Alefacept Alone in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Lead sponsor
Astellas Pharma Inc
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2007
Completion date
December 31, 2009
Enrollment
98 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

plaque psoriasis